Health Trials

Relapsed or Refractory Non-Hodgkin Lymphoma

1

Review clinical trials related to Relapsed or Refractory Non-Hodgkin Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

This is a multi-center, non-randomized and open-label phase I/IIa clinical study to evaluate the safety, tolerability, and efficacy of ICP-490 in patients with relapsed or refractory non-hodgkin lymphoma.

Participants needed: 68
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Beijing InnoCare Pharma Tech Co., Ltd.Updated: Feb 25, 2025Locations: 6
Eligibility criteria

Aged ≥ 18 years old. [+8]

Known active central nervous system (CNS) involvement Lymphoma. [+9]

Read more